Research Company that is focusing on the development of liposomal and advanced products, Nanodorf has developed innovative techniques for preparing liposomes.
Nanodorf's mission is to support companies in developing sophisticated products by streamlining the launch and marketing processes. The company provides a cost-effective approach to product development and manufacturing, enabling businesses to bring their products to market with minimal initial investment, alleviating the challenges associated with complex development processes.
Nanodorf's vision is to develop radical solutions for controversial and incurable diseases. The company focuses on several critical healthcare challenges, including:
Antimicrobial Resistance (AMR), Anticancer Therapies, Antiviral Agents, Acute Respiratory Distress Syndrome (ARDS) and H. pylori.
Nanodorf’s extraordinary, unprecedented, cost effective, easily scalable, and achieves the operational excellence technique will revolutionize the manufacturing of liposomal products, it will increase the capacity of manufacturing sites multiple times, this will be the main solution for liposomal products shortage.
Doxorubicin PEGylated Liposomal Injection
Amphotericin Lyophilized Liposomal Injection
Alpha Lipoic Acid (ALA), is one of the most crucial, safe and effective supplements for neuropathy specially diabetic neuropathy, it is used extensively, despite its low bioavailability. Many drawbacks come from ALA low melting point, one is related to higher disintegration time during shelf life, that leading to low absorption and lower bioavailability, and the most irritating to the manufacturers is the stickiness during capsule filling and tablet compression processes.
Nanodorf’s ALA product solves all these problem with an unprecedented coating with colloidal silicone dioxide and micronization.
Novel Liposomes for new molecule that has not been developed yet, with nanodorf will no longer takes much more time for development, scaling up, and finally commercialization, thanks for the revolutionary technique for liposomal development and preparation by nanodorf.
Novel Liposomes for existing liposomal molecules which has been developed earlier but still needs enhancement either to decrease toxicity or increase efficacy, which could be achieved smoothly by nanodorf.
No more sophistication, no more extended time for manufacturing liposomes, and no more costly processes for manufacturing liposomes, nanodorf is totally able to make the process of commercialized product much more easier, less time and at the lowest cost.